Takeda (NYSE:TAK) and Protagonist Therapeutics (NASDAQ:PTGX) secured a major regulatory milestone on Monday as the U.S. Food and Drug Administration (FDA) granted Priority Review to rusfertide, an investigational treatment for polycythemia vera (PV).
Venture Global (NYSE:VG) and Trafigura announced a new, binding liquefied natural gas (LNG) supply agreement on Monday, marking a strategic shift toward mid-term contracting for the Arlington-based energy producer.
Alaunos Therapeutics (NASDAQ:TCRT) released proof-of-concept data from two separate diet-induced obesity (DIO) mouse studies on Monday, marking a strategic pivot toward non-hormonal metabolic treatments.
Ocugen (NASDAQ:OCGN) announced Monday that it has completed patient enrollment for its pivotal Phase 3 liMeliGhT clinical trial, evaluating OCU400 for the treatment of retinitis pigmentosa (RP).
Pharvaris (NASDAQ:PHVS) dominated the clinical spotlight at the American Academy of Allergy, Asthma & Immunology (AAAAI) 2026 meeting on Monday, unveiling full data from its RAPIDe-3 and CHAPTER-1 trials.
Highway Holdings (NASDAQ:HIHO), a Hong Kong-based manufacturer of precision metal components and provider of contract manufacturing services, on Monday reported financial results for its third quarter and nine-month period ended December 31, 2025.
The Hain Celestial Group (NASDAQ:HAIN) finalized a major structural overhaul on Monday with the completed sale of its North American snacks portfolio to Snackruptors.
StealthGas (NASDAQ:GASS) delivered a strong financial performance for the fourth quarter and full year 2025, reporting a net income of $12.8 million for the final three months of the year.
Sionna Therapeutics (NASDAQ:SION) entered 2026 with a substantial financial cushion, reporting $310.3 million in cash, cash equivalents, and marketable securities as of December 31, 2025.
HBT Financial (NASDAQ:HBT), the holding company for Heartland Bank and Trust Company, announced Monday that it has successfully completed its merger with CNB Bank Shares.
AES (NYSEAES) announced Monday that it has entered into a definitive merger agreement to be taken private by a consortium of heavyweight infrastructure investors.
Uniti Group (NASDAQ:UNIT) reported a fourth-quarter net loss of $305.7 million on Monday, reflecting the heavy financial lifting required to complete its massive merger with Windstream.
